Please wait while the formulary information is being retrieved.
VECAMYL (MECAMYLAMINE HCL)
- Hypertension
2.5 mg tablet
- 1 tablet (2.5 mg) by oral route once daily
Hypertension
- 2 tablets (5 mg) by oral route 3 times per day
- 2 tablets (5 mg) by oral route 2 times per day and 3 tablets (7.5 mg) once daily
- 2 tablets (5 mg) by oral route once daily and 3 tablets (7.5 mg)2 times per day
- 1 tablet (2.5 mg) by oral route once daily
- 3 tablets (7.5 mg) by oral route 3 times per day
- 3 tablets (7.5 mg) by oral route 2 times per day and 4 tablets (10 mg) once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- 30 day risk period post-myocardial infarction
- Chronic myocardial ischemia
- Glaucoma
- Pyloroduodenal obstruction
Contraindicated
- Kidney disease with reduction in GFR
Severe
Moderate
- Alcohol intoxication
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Cerebrovascular insufficiency
- Hyponatremia
- Urethral stricture
VECAMYL (MECAMYLAMINE HCL)
- Hypertension
- Hypotension
- Orthostatic hypotension
- Constipation
- Drowsy
- Fatigue
More Frequent
Severe
Less Severe
- Dysuria
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Altered mental status
- Chorea
- Paralytic ileus
- Pulmonary edema
- Pulmonary fibrosis
- Seizure disorder
- Tremor
Less Severe
- Abnormal sexual function
- Anorexia
- Blurred vision
- Erectile dysfunction
- Libido changes
- Nausea
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Mecamylamine Hydrochloride
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Mecamylamine Hydrochloride
Molecular wt low enough for possible breastmilk excretion,use caution
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Molecular wt low enough for possible breastmilk excretion,use caution |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Hypertension | |
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| 0-9 | A-Z |
|---|---|
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
Formulary Reference Tool